Edition:
United Kingdom

Aytu BioScience Inc (AYTU.OQ)

AYTU.OQ on NASDAQ Stock Exchange Capital Market

1.07USD
15 Feb 2019
Change (% chg)

$0.03 (+2.88%)
Prev Close
$1.04
Open
$1.06
Day's High
$1.08
Day's Low
$1.02
Volume
16,544
Avg. Vol
88,237
52-wk High
$37.40
52-wk Low
$0.69

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.33 June 16 Feb 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 1 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.00 1.00 1.00 1.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 1 2.58 2.58 2.58 --
Quarter Ending Dec-19 1 3.14 3.14 3.14 --
Year Ending Jun-19 2 7.36 7.56 7.16 --
Year Ending Jun-20 2 12.73 12.97 12.50 --
Earnings (per share)
Quarter Ending Sep-19 1 -0.33 -0.33 -0.33 --
Quarter Ending Dec-19 1 -0.22 -0.22 -0.22 --
Year Ending Jun-19 2 -2.53 -2.07 -2.99 --
Year Ending Jun-20 2 -1.01 -0.93 -1.09 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 1.69 1.79 0.10 6.06
Quarter Ending Sep-18 1.33 1.43 0.11 8.06
Quarter Ending Mar-18 1.25 0.61 0.64 51.40
Quarter Ending Dec-17 1.30 1.05 0.25 19.14
Quarter Ending Sep-17 1.10 1.08 0.02 2.18

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 2.58 2.58 2.58 -- --
Quarter Ending Dec-19 3.14 3.16 3.16 -- --
Year Ending Jun-19 7.36 7.33 7.33 7.16 --
Year Ending Jun-20 12.73 12.68 12.68 12.50 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-19 0 0 0 0
Quarter Ending Dec-19 0 1 0 1
Year Ending Jun-19 1 0 1 0
Year Ending Jun-20 1 0 1 0
Earnings